BACKGROUND: This study was designed to describe the impact of smoking on health status and mortality after percutaneous coronary intervention (PCI). METHODS: A cohort of 271 consecutive PCI patients at the Mid-America Heart Institute of St Luke's Hospital in Kansas City, Mo, were observed in a prospective, observational study. Surveys that included health status assessments were administered at baseline and at 6 and 12 months after intervention. Primary outcome was health status as measured by the Short Form-12 (SF-12) and the Seattle Angina Questionnaire (SAQ). RESULTS: Risk-adjusted statistical models demonstrated that, across a number of health-related quality of life domains, patients who were current smokers had poorer health status outcomes than other patients after revascularization. For instance, patients who had never smoked (P <.001) and patients who were former smokers (P <.001) scored significantly higher than patients who were current smokers on the physical component score of the SF-12, which indicated a better sense of overall physical function. Similarly, patients who had never smoked and patients who were former smokers reported significantly fewer physical limitations, less angina, and a higher quality of life on the SAQ than patients who were current smokers. Smoking status was unrelated to mortality rate in the 12 months after revascularization. CONCLUSIONS: Smoking substantially limits the potential health status benefits of PCI.
BACKGROUND: This study was designed to describe the impact of smoking on health status and mortality after percutaneous coronary intervention (PCI). METHODS: A cohort of 271 consecutive PCI patients at the Mid-America Heart Institute of St Luke's Hospital in Kansas City, Mo, were observed in a prospective, observational study. Surveys that included health status assessments were administered at baseline and at 6 and 12 months after intervention. Primary outcome was health status as measured by the Short Form-12 (SF-12) and the Seattle Angina Questionnaire (SAQ). RESULTS: Risk-adjusted statistical models demonstrated that, across a number of health-related quality of life domains, patients who were current smokers had poorer health status outcomes than other patients after revascularization. For instance, patients who had never smoked (P <.001) and patients who were former smokers (P <.001) scored significantly higher than patients who were current smokers on the physical component score of the SF-12, which indicated a better sense of overall physical function. Similarly, patients who had never smoked and patients who were former smokers reported significantly fewer physical limitations, less angina, and a higher quality of life on the SAQ than patients who were current smokers. Smoking status was unrelated to mortality rate in the 12 months after revascularization. CONCLUSIONS: Smoking substantially limits the potential health status benefits of PCI.
Authors: Jason M Holland; Alan F Schatzberg; Ruth O'Hara; Renee M Marquett; Dolores Gallagher-Thompson Journal: Psychiatry Res Date: 2013-08-14 Impact factor: 3.222
Authors: Jae-Sik Jang; Donna M Buchanan; Kensey L Gosch; Philip G Jones; Praneet K Sharma; Ali Shafiq; Anna Grodzinsky; Timothy J Fendler; Garth Graham; John A Spertus Journal: Circ Cardiovasc Interv Date: 2015-05 Impact factor: 6.546
Authors: Mohammad A Sherif; Christoph A Nienaber; Ralph Toelg; Mohamed Abdel-Wahab; Volker Geist; Steffen Schneider; Jochen Senges; Karl-Heinz Kuck; Ulrich Tebbe; Gert Richardt Journal: Clin Res Cardiol Date: 2010-12-01 Impact factor: 5.460
Authors: Donna M Buchanan; Suzanne V Arnold; Kensey L Gosch; Philip G Jones; Lance S Longmore; John A Spertus; Sharon Cresci Journal: Circ Cardiovasc Qual Outcomes Date: 2015-09
Authors: Jan C van den Berge; Karolijn Dulfer; Elisabeth M W J Utens; Eline M J Hartman; Joost Daemen; Robert J van Geuns; Ron T van Domburg Journal: Int J Cardiol Heart Vasc Date: 2016-03-16